Canine oxygen carrier manufacturing restoration and regulatory activities

Active Definitive Contract Awarded Last action

Contract number
HT942525C0035
Awardee
Awarding agency
Obligated
$9,559,948

Award facts

Opportunity
  • HT942525R0014 Solicitation number
Contract value 76% obligated
$12,534,579.00 Current and potential, with all options
Completion date 36% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Souderton, PA 18964, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Funding Only Action P00003 $819,899
Funding Only Action P00002 $787,486
Supplemental Agreement for work within scope P00001 $500,000
Original award $7,452,563

About this award

The Defense Health Agency awarded a $12.534 million definitive contract to Hemoglobin Oxygen Therapeutics LLC for canine oxygen carrier manufacturing, restoration, and regulatory activities on June 1, 2025.

Place of performance is Souderton, PA. The contract carries a firm fixed price and runs through May 31, 2029.

Quick answers

Who was awarded contract HT942525C0035?

HT942525C0035 was awarded to Hemoglobin Oxygen Therapeutics LLC by Defense Health Agency (Department of Defense) on June 1, 2025.

How much is contract HT942525C0035 worth?

The government has obligated $9,559,948 on HT942525C0035. Its current value, with exercised options, is $12,534,579.

Was contract HT942525C0035 competed?

The extent of competition for HT942525C0035 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award